Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Del Williams
Mitigate risk, prevent safety issues by utilizing closed conveyor systems designed with sanitation in mind
Dirk Dusharme @ Quality Digest
Companies say they plan to pull some or all of their devices
Dirk Dusharme @ Quality Digest
First step, migrate your QMS to a cloud-based electronic quality management system
Jill Roberts
Another way to know what’s too old to eat
Patricia Santos-Serrao
Four pharma quality trends

More Features

FDA Compliance News
Showcasing tech, solutions, and services at Gulfood Manufacturing 2022
Easy, reliable leak testing with methylene blue
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community
Good quality is adding an average of 11 percent to organizations’ revenue growth
Further enhances change management capabilities

More News


FDA Compliance

Current Good Manufacturing Practices Conference

Co-sponsored by ISPE and FDA, June 4–5, 2012, in Baltimore

Published: Thursday, March 15, 2012 - 11:38

(ISPE: Tampa, FL) -- The Food and Drug Administration (FDA) has joined with the International Society for Pharmaceutical Engineering (ISPE) to deliver an integrated learning conference focused on industry and regulatory viewpoints concerning current good manufacturing practices (CGMP). The conference, “Redefining the ‘C’ in CGMP—Creating, Implementing, and Sustaining a Culture of Compliance,” will be held in Baltimore, June 4–5, 2012. It is the first joint ISPE-FDA conference focused on CGMP issues.

The conference will feature a new format with a number of audience-participation and interactive sessions. Attendees engage in discussion with regulators on critical industry issues, concerns, and collaboration during the Hot Topic Discussion Forum. A mixed panel of FDA and industry leaders will answer the industry’s most pressing questions during a moderated “Meet the Press” session. Topical plenary and education sessions will be featured throughout the two-day event.

“This first annual co-sponsored conference reflects ISPE’s commitment to engaging its members, companies, and global regulatory agencies in dialogue around critical problem solving and learning,” says ISPE president and CEO Nancy Berg. “As the independent pharmaceutical manufacturing association, ISPE is dedicated to strengthening industry through relevant technical education, training, and networking. This new conference hits the mark, assembling the entire supply chain to discuss industry’s commitment to identifying and adopting quality and manufacturing techniques that continue to deliver a safe, consistent, and available drug supply.”

“FDA is very excited to be working on this joint conference,” says Steven Lynn, the acting director, FDA/CDER/Office of Compliance/Office of Manufacturing and Product Quality. “Our goal is to make this a highly collaborative agency and industry conference, where we can come together to discuss the current and future state of CGMPs in the quest to ensure high-quality, fit-for-use drugs are continually available to the community that we serve.”

More information on the Redefining the “C” in CGMP Conference is available here.


About The Author

ISPE’s picture


The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association of 22,000 pharmaceutical professionals in 90 countries who use knowledge to create high-quality, cost-effective good manufacturing practices (GMP) solutions. ISPE provides its members opportunities to develop technical knowledge, exchange practical experience within their community, enhance their professional skills, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE offers online learning for a global audience. Its world headquarters are in Tampa, Florida, with offices in Brussels, Belgium, Shanghai, China, and Singapore.